IL Chicago의 자궁내막암 임상 시험
자궁내막암 관련 연구 23개가 Chicago 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
피험자 모집 중1/2상
- University of Illinois at Chicago (UIC), Chicago
- University of Chicago, Chicago
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
피험자 모집 중1상
- University of Chicago Comprehensive Cancer Center, Chicago
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
피험자 모집 중2상
- Mount Sinai Hospital Medical Center, Chicago
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- 외 3개
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
피험자 모집 중2상
- Northwestern University, Chicago
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
피험자 모집 중3상
- University of Chicago Medical Center ( Site 5002), Chicago
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
피험자 모집 중3상
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
피험자 모집 중관찰 연구
- University of Chicago, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
피험자 모집 중2상
- University of Illinois Cancer Center, Chicago
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
피험자 모집 중
- Northwestern Memorial Hospital, Chicago
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
피험자 모집 중1상
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
피험자 모집 중1상
- University of Chicago Medical Center, Chicago
A Study of PHST001 in Advanced Solid Tumors
피험자 모집 중1상
- University of Chicago Medical Center, Chicago
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
피험자 모집 중1/2상
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago Medical Center, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
피험자 모집 중1상
- Northwestern University Feinberg School of Medicine, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
피험자 모집 중1/2상
- Lurie Children's Hospital-Chicago, Chicago
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
피험자 모집 중2상
- Northwestern Medicine, Chicago
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
피험자 모집 중1/2상
- University of Chicago Medical Center, Chicago
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
피험자 모집 중3상
- Research Site, Chicago
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
피험자 모집 중1/2상
- Northwestern University, Chicago
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
피험자 모집 중1/2상
- Northwestern Memorial Hospital, Chicago
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
피험자 모집 중1/2상
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Chicago
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
피험자 모집 중관찰 연구건강한 지원자 환영
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
다른 도시의 자궁내막암 시험
- Houston, TX연구 69개
- New York City, NY연구 54개
- Boston, MA연구 51개
- Arlington, VA연구 41개
- Nashville, TN연구 38개
- Los Angeles, CA연구 35개
- St. Louis, MO연구 29개
- Philadelphia, PA연구 29개
- Oklahoma City, OK연구 28개
- San Antonio, TX연구 27개
- Queens, NY연구 26개
- Dallas, TX연구 25개
Chicago의 다른 연구
- 유방암연구 59개
- 비소세포폐암연구 59개
- 암 (전체)연구 51개
- 전립선암연구 45개
- 폐암연구 43개
- 전이성 암연구 42개
- 비만연구 40개
- 난소암연구 36개
- 대장직장암연구 32개
- 뇌졸중연구 31개
- 두경부 편평세포암연구 29개
- 과체중연구 29개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.